GlassScriptPhysician profile
Kale D Dittmeyer
NPI 1609036755
$1,294.48
in general payments reported to CMS, 2019-2025
14 companies · $75.96 in 2025
The $75.96 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $81.74 · 2021: $258 · 2022: $384 · 2023: $240 · 2024: $34.93 · 2025: $75.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $440.19 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $258.55 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $153.12 | 2023 | Myfembree |
| Myovant Sciences INC. | $144.86 | 2022 | |
| Hologic Sales and Service, LLC | $133.09 | 2021-2025 | Aptima, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System |
| Allergan, INC. | $26.24 | 2019 | |
| Therapeuticsmd, INC. | $24.52 | 2019 | |
| Medtronic, INC. | $23.34 | 2023 | Truclear |
| Bayer Healthcare Pharmaceuticals INC. | $18.07 | 2020 | |
| Horizon Therapeutics Plc | $15.49 | 2020 | |
| Merck Sharp & Dohme LLC | $15.36 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.19 | 2019 | |
| Lupin INC. | $15.05 | 2019 | |
| Covidien LP | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kale Dittmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.